Related Scientific Literature
- Test performance evaluation of SARS-CoV-2 serological assays
- Comparison of four new commercial serologic assays for determination of SARS-CoV-2 IgG
- Challenges in Laboratory Diagnosis of the Novel Coronavirus SARS-CoV-2
- Diagnostic accuracy of two commercially available rapid assays for detection of IgG and IgM antibodies to SARS-CoV-2 compared to ELISA in a low-prevalence population
- Diagnostic accuracy of serological tests for covid-19: systematic review and meta-analysis
- RT-PCR testing to detect a COVID-19 outbreak in Austria: rapid, accurate and early diagnosis in primary care (The REAP study)
- Evaluation of two commercial and two non-commercial immunoassays for the detection of prior infection to SARS-CoV-2
- Evaluation of a novel multiplexed assay for determining IgG levels and functional activity to SARS-CoV-2
- Molecular and Immunological Diagnostic Tests of COVID-19: Current Status and Challenges
- Comparison of test performance of commercial anti-SARS-CoV-2 immunoassays in serum and plasma samples
- Immunological assays for SARS-CoV-2: an analysis of available commercial tests to measure antigen and antibodies
- Performance characteristics of four high-throughput immunoassays for detection of igg antibodies against sars-cov-2
- Performance evaluation of serological assays to determine the immunoglobulin status in SARS-CoV-2 infected patients
- Comparison of the Elecsys® Anti-SARS-CoV-2 immunoassay with the EDI™ enzyme linked immunosorbent assays for the detection of SARS-CoV-2 antibodies in human plasma
- Assay Techniques and Test Development for COVID-19 Diagnosis.
- Antibody response using six different serological assays in a completely PCR-tested community after a COVID-19 outbreak - the CoNAN study
- Meta-analysis of the clinical performance of commercial SARS-CoV-2 nucleic acid, antigen and antibody tests up to 22 August 2020
- Evaluation of the EDI enzyme linked immunosorbent assays for the detection of SARS-CoV-2 IgM and IgG antibodies in human plasma
- Analysis of COVID-19 convalescent plasma for SARS-CoV-2 IgG using two commercial immunoassays
- Point-of-care serological assays for delayed SARS-CoV-2 case identification among health-care workers in the UK: a prospective multicentre cohort study
- Evaluation of six commercial mid to high volume antibody and six point of care lateral flow assays for detection of SARS-CoV-2 antibodies
- Comparison of SARS-CoV-2 serological tests with different antigen targets
- Specificity and Performance of Nucleocapsid and Spike-based SARS-CoV-2 Serologic Assays
- Testing-on-a-probe biosensors reveal association of early SARS-CoV-2 total antibodies and surrogate neutralizing antibodies with
- Performance of SARS-CoV-2 serology tests: Are they good enough?
- Kinetics of Nucleo- and Spike Protein-Specific Immunoglobulin G and of Virus-Neutralizing Antibodies after SARS-CoV-2 Infection.